Shulman DeMeo Asset Management LLC bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the third quarter, Holdings Channel reports. The fund bought 8,665 shares of the conglomerate’s stock, valued at approximately $1,920,000. Danaher makes up approximately 0.7% of Shulman DeMeo Asset Management LLC’s portfolio, making the stock its 21st largest holding.
Several other institutional investors and hedge funds have also modified their holdings of the business. Main Street Group LTD acquired a new stake in Danaher in the 1st quarter worth about $25,000. N.E.W. Advisory Services LLC acquired a new position in shares of Danaher during the 2nd quarter worth approximately $25,000. Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the 4th quarter worth approximately $27,000. Clal Insurance Enterprises Holdings Ltd raised its position in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares in the last quarter. Finally, Evolution Wealth Management Inc. boosted its stake in shares of Danaher by 208.0% in the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after buying an additional 104 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
DHR has been the topic of a number of recent research reports. Piper Sandler assumed coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. The Goldman Sachs Group increased their target price on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a report on Monday, September 21st. Barclays raised their price target on Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research report on Wednesday. Evercore reaffirmed an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Finally, Guggenheim upped their price objective on shares of Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $235.23.
Danaher Price Performance
Shares of DHR stock traded up $2.69 on Friday, hitting $220.15. 3,934,329 shares of the company’s stock were exchanged, compared to its average volume of 4,457,726. The company has a 50 day moving average of $211.38 and a 200 day moving average of $194.62. The stock has a market cap of $154.76 billion, a P/E ratio of 39.10, a price-to-earnings-growth ratio of 2.72 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.77 earnings per share. On average, equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current year.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio is presently 28.42%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
See Also
- Five stocks we like better than Danaher
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
